Pregnancy induced displacement of preexisting microchimeric cells in the absence of maternal B and T cells

Front Immunol. 2024 Oct 30:15:1478465. doi: 10.3389/fimmu.2024.1478465. eCollection 2024.

Abstract

Bidirectional exchange of cells between mother and fetus occurs during pregnancy, and persistence of these genetically foreign cells establishes long-term microchimerism in both individuals after parturition. Since women can have multiple pregnancies, and all mothers were once daughters themselves, the microchimeric milieu in each woman could theoretically contain cells from a variety of origins, including from their own mothers as well as their babies from each pregnancy. Interestingly and in sharp contrast to this prediction, we recently showed preexisting populations of microchimeric cells are lost following pregnancy and associated with seeding of new fetal microchimeric cells. Complete loss of preexisting microchimeric cells in this context draws parallels to immunological rejection with synchronized elimination of cells and tissues that express defined discordant antigens. This perspective evaluates this provocative hypothesis regarding pregnancy induced rejection of microchimeric cells, including new experimental data comparing microchimerism levels in mice simultaneously lacking B and T cells before pregnancy, and after parturition with primary and secondary pregnancies.

Keywords: B cell; RAG1; T cell; immune tolerance; microchimerism; microchiome; non-inherited maternal antigen; reproductive fitness.

MeSH terms

  • Animals
  • B-Lymphocytes* / immunology
  • Chimerism*
  • Female
  • Fetus / cytology
  • Fetus / immunology
  • Humans
  • Maternal-Fetal Exchange* / immunology
  • Mice
  • Pregnancy
  • T-Lymphocytes* / immunology

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported in part by NIH-NIAID through grants R01-AI175431 and R01-AI184537, the Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award (grant #1011031) and March of Dimes Ohio Prematurity Research Collaborative. LT was supported by the NIAID through Vaccinology Training Program NIH-NIAID T32-AI165396.